Lorundrostat

SCHEMBL29536765

Br.CC(=O)N[C@H]1CC[C@H](NC(=O)CN2CCN(c3nncc(-c4ccc(C)cc4)n3)CC2)CC1

nearest known ligand 0.98

Known targets — ChEMBL curated mechanism

ACHE ADRA1A ADRA1B ADRA1D ADRA2A ADRA2B ADRA2C ADRB1 ADRB2 ADRB3 APH1A APH1B CHRM2 CHRM3 EZH2 GRIN2A HTR1A HTR1B HTR1D HTR1F HTR3A NCSTN P2RY12 PSEN1 PSEN2 PSENEN SIGMAR1 SLC6A2 SLC6A3 SLC6A4

The experimentally established mechanism targets of Lorundrostat. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

	gene	UniProt	supporting neighbours	confidence
▸	CYP11B2	P19099	20/20	0.98

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Lorundrostat SCHEMBL25323630	1.00	CYP11B2 (0.98)	CYP11B2
Lorundrostat SCHEMBL25323633	1.00	CYP11B2 (0.98)	CYP11B2
Lorundrostat SCHEMBL29501060	0.99	CYP11B2 (1.00)	CYP11B2
Lorundrostat SCHEMBL25323514	0.99	CYP11B2 (1.00)	CYP11B2
Lorundrostat SCHEMBL18489931	0.99	CYP11B2 (1.00)	CYP11B2
SCHEMBL27132479	0.90	CYP11B2 (0.84)	CYP11B2
SCHEMBL18489903	0.89	CYP11B2 (1.00)	CYP11B2
SCHEMBL18502893	0.86	CYP11B2 (0.76)	CYP11B2
SCHEMBL18489968	0.85	CYP11B2 (0.84)	CYP11B2
SCHEMBL28557916	0.85	CYP11B2 (0.84)	CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4232011-A1	CYP11B2 BETA HYDROXYLASE INHIBITORS FOR HYPERTENSION	Mineralys Therapeutics, Inc. (US)	2023-08-30	—	—	EP	disclosed
WO-2022093714-A1	CYP11B2 BETA HYDROXYLASE INHIBITORS FOR HYPERTENSION	MINERALS THERAPEUTICS, INC. (US)	2022-05-05	—	—	WO	disclosed